The oncogenic fusion kinase BCR-ABL activates the anti-apoptotic protein Bcl-2 to protect mitochondria from DNA-damaged signals and prevent apoptosis in chronic myelogenous leukemia (CML) [207, 208]. Here, BCL2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.